Skip to main content
Clinical Trials/NCT05218967
NCT05218967CompletedNot Applicable

Virtual Reality as a Distraction Intervention for Pain Management During Office Laryngeal Procedures: Randomized Single Blinded Clinical Trial

Weill Medical College of Cornell University2 sites in 1 country40 target enrollmentStarted: February 14, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Physician Questionnaire

Study Overview

Brief Summary

The purpose of this study is to compare patient's pain and anxiety undergoing laryngeal procedures and esophageal manometry while wearing a VR headset to standard of care. It is hypothesized that patient's using the VR headset during the procedure will have reduced pain and anxiety as compared to their standard of care counterparts because the VR environment will distract them from their procedure.

Detailed Description

This is a prospective randomized controlled trial, comparing patients' pain and anxiety experience while wearing a VR headset and receiving standard analgesia during In-office aerodigestive procedures (IOAEP) to patients' experience receiving standard analgesia only during IOAEP.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients (18 or older)
  • Patients scheduled for IOAEP, including laryngeal biopsies, percutaneous injection laryngoplasty, KTP ablation of hemorrhagic polyps and respiratory papilloma, and transnasal esophagoscopy (TNE), and esophageal manometry.

Exclusion Criteria

  • Patients under 18 years of age
  • Patients unable to consent
  • Non-English-speaking patients
  • Patients who have undergone prior IOAEP
  • Patients who have used any psychotropic or analgesic medication within the last 24 hours due to the possible confounding effect on pain or anxiety perception
  • Patients with motion sickness or uncorrected visual impairment (legal blindness)
  • Patients with past medical history of seizures or visual abnormalities

Outcomes

Primary Outcomes

Physician Questionnaire

Time Frame: Immediately After Procedure

Clinicians will fill out a short 6 question survey about the use of VR during their procedure. The survey is a short 6 item questionnaire inquiring about difficulty and success of the procedure, perceived patients' discomfort, observed patient agitation, interference and benefit of the VR headset. These questions will be answered using a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).

Galvanic Skin Activity

Time Frame: Measures will be recorded immediately before and immediately after the procedure.

Galvanic Skin Activity will be measured through AD instruments PowerLab

Anxiety during the procedure , as measured by the spielberger State-Trait Anxiety Inventory (SF- STAI)

Time Frame: During Procedure

The STAI consists of 6 questions concerning patient's current state of anxiety with responses ranging from (1) never to almost always (4).

Pain during procedure, as measured by the McGill Pain Questionnaire

Time Frame: During Procedure

individually rated pain descriptors with 11 addressing sensory pain and 4 focusing on affective components of pain. Each item is rated on a 4-point scale that ranges from none to severe.

Heart rate

Time Frame: Measures will be recorded immediately before and immediately after the procedure.

Heart rate will will be measured through AD instruments PowerLab.

Temperature

Time Frame: Measures will be recorded immediately before and immediately after the procedure.

Temperature will be measured through AD instruments PowerLab

Pain as measured by the Visual Analog Scale

Time Frame: Measures will be recorded immediately after the procedure.

Visual Analog Pain Scale measured pain on range from 0-100 (0 is no pain and 100 is max pain) about time of pain, unpleasantness, average pain, and worst pain on a scale of 0-100.

Upper Esophageal Sphincter Pressure

Time Frame: During the Procedure

Upper Esophageal Sphincter Pressure will be measured through the probe inserted during the High Resolution Manometry

Post Procedure Patient Questionnaire

Time Frame: Immediately After Procedure

Patients will be asked if they would repeat the procedure again on a scale of 1-5 with 1 being never and 5 being always.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials